Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

0.0%

0 terminated out of 28 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

11%

3 trials in Phase 3/4

Results Transparency

0%

0 of 5 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

17Total
Not Applicable (8)
P 1 (2)
P 2 (4)
P 3 (2)
P 4 (1)

Trial Status

Recruiting13
Enrolling By Invitation6
Completed5
Not Yet Recruiting2
Active Not Recruiting1
Unknown1

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 5 completed trials

Clinical Trials (28)

Showing 20 of 20 trials
NCT07575672Phase 3Not Yet RecruitingPrimary

Finerenone in Patients Undergoing Transcatheter Aortic Valve Implantation With Heart Failure

NCT06762964Phase 2Recruiting

CAMEO-FONTAN -Dapagliflozin in the Failing Fontan Circulation

NCT05637398Phase 1CompletedPrimary

Colchicine in Patients With Heart Failure and Preserved Left Ventricular Ejection Fraction

NCT06994325Not ApplicableEnrolling By InvitationPrimary

Testing the CHAT Program for Patients With Heart Failure

NCT07298993Phase 4Enrolling By Invitation

Deprescribing Beta-Blockers in Elders With Heart Failure With Preserved Ejection Fraction (DEPRESCRIBE-HFpEF)

NCT07416279Not ApplicableRecruitingPrimary

Can Tiny Bubbles Offer an Alternative to Catheters for Assessing Pressures Inside the Heart? Investigating Ultrasound Contrast Agents as Pressure Sensors Against Gold Standard Catheter Pressures in Cardiac Catheterisation Patients.

NCT06914102Completed

Emulation of the STEP-HFpEF DM Heart Failure Trial in Healthcare Claims Data

NCT06914141Completed

Comparative Effectiveness of Tirzepatide Versus Semaglutide in Individuals With Heart Failure With Preserved Ejection Fraction

NCT07221513Phase 2Recruiting

Study of JK07 in Patients With Heart Failure and WHO Group 2 Combined Post- and Pre-Capillary Pulmonary Hypertension

NCT05784753Not ApplicableRecruitingPrimary

HEART Camp Connect -Promoting Exercise in Adults With Heart Failure With Preserved Ejection Fraction

NCT06650995Not ApplicableRecruitingPrimary

AlEX-DHF: Ablation and Exercise in Diastolic Heart Failure

NCT07223242Phase 2RecruitingPrimary

Tailored Exercise Training Study Among Adults With HFpEF

NCT07215715RecruitingPrimary

US Benchmarking Clinical Study

NCT06670001Not ApplicableRecruitingPrimary

MOVE-HF MOtivating Physical Activity With BehaVioral Economics in Heart Failure With Preserved Ejection Fraction

NCT07077811Not ApplicableEnrolling By Invitation

The Safety and Efficacy of Pulsed Field Ablation for Patients With Persistent Atrial Fibrillation Comorbid With HFpEF.

NCT04826159Phase 2Completed

IMPROVE-DiCE: Study to Evaluate Effect of IMB-1018972 on Cardiac Energetics in T2DM & Obesity (Pt 1) With HFpEF (Pt 2)

NCT07015554Enrolling By InvitationPrimary

Serum IGF1 on Female HFpEF Patients

NCT06774014Recruiting

Heart Failure in Patients With Diabetes: Cells, Crosstalk and Consequences

NCT06837623Phase 3Active Not RecruitingPrimary

Role of Colchicine as Anti-Inflammatory Therapy in HFpEF

NCT06699056Recruiting

AI-Enabled Direct-from-ECG Ejection Fraction (EF) Severity Assessment Using COR ECG Wearable Monitor

Scroll to load more

Research Network

Activity Timeline